Manager, Global Compensation at Legend Biotech

Franklin Township, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

Strong analytical rigor and process discipline
Expertise in compensation systems, HRIS, and reporting tools
Ability to partner with stakeholders including HRBPs, Finance, Legal, HRIS, and Talent Acquisition
Experience with global compensation programs, equity administration, and labor cost modeling

Responsibilities

Lead the execution of annual compensation cycles including merit, promotion, and bonus planning; establish and manage data templates, process timelines, and system configurations; partner with HRIS, HRBPs, and Finance for accurate planning, validation, and reporting
Manage end-to-end equity operations including grant issuance, vesting schedules, tracking, and reporting; collaborate with Legal, Finance, and stock plan administrators for compliance and timely execution; maintain equity data integrity and support employee communications and inquiries
Lead the development of annual labor cost models to support workforce planning and budgeting; own monthly compensation reporting, trend analysis, and variance tracking for HR and Finance stakeholders; deliver insights and recommendations based on labor cost trends and forecasts
Manage participation in global compensation surveys, including data submission and validation; analyze survey results and prepare benchmarking reports to inform market pricing and pay positioning; maintain survey library and ensure consistent methodology across geographies
Own the development and delivery of compensation dashboards, reports, and data visualizations; analyze compensation trends, identify risks, and provide actionable insights to HR and business leaders; ensure data accuracy and consistency across systems and reporting tools
Develop and maintain compensation policies, guidelines, and process documentation; ensure policies are current, compliant, and effectively communicated across HR and business teams
Lead job evaluations and market pricing using survey data and internal benchmarks; partner with HRBPs to understand job scope and responsibilities, and make leveling decisions; provide offer pricing recommendations in partnership with Talent Acquisition
Own the global recognition platform, including vendor relationship management, system configuration, and award tracking; establish programs

Skills

Compensation Planning

Equity Administration

Labor Cost Modeling

Survey Benchmarking

HRIS

Analytics

Reporting

Merit Planning

Bonus Planning

Process Management

Legend Biotech

Develops and commercializes cell therapies

About Legend Biotech

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.

Franklin Township, New JerseyHeadquarters

2014Year Founded

$146.4MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Sick Leave

Paid Holidays

Remote Work Options

Risks

Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.

Collaboration with Multiply Labs may face technological challenges, delaying production timelines.

Financial strain from new R&D facility could affect operational focus if advancements lag.

Differentiation

Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.

The company is technology agnostic, exploring multiple platforms for effective cancer treatments.

Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Upsides

Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.

New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.

Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

Land your dream remote job 3x faster with AI

Try Jobo Free